The estimated Net Worth of Ventures Llc Remeditex is at least $208 Million dollars as of 30 June 2020. Ventures Remeditex owns over 120,481 units of Soliton stock worth over $208,058,375 and over the last 10 years Ventures sold SOLY stock worth over $0.
Sign up
Ventures Remeditex SOLY stock SEC Form 4 insiders trading
Ventures has made over 4 trades of the Soliton stock since 2018, according to the Form 4 filled with the SEC. Most recently Ventures bought 120,481 units of SOLY stock worth $999,992 on 30 June 2020.
The largest trade Ventures's ever made was buying 357,143 units of Soliton stock on 19 June 2019 worth over $8,064,289. On average, Ventures trades about 91,613 units every 111 days since 2014. As of 30 June 2020 Ventures still owns at least 9,214,277 units of Soliton stock.
You can see the complete history of Ventures Remeditex stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Ventures Remeditex's mailing address?
Ventures's mailing address filed with the SEC is 2727 N Harwood St #200, Dallas, TX 75201, USA.
Insiders trading at Soliton
Over the last 5 years, insiders at Soliton have traded over $0 worth of Soliton stock and bought 632,904 units worth $999,992 . The most active insiders traders include Walter V Klemp, Ventures Llc Remeditex, and Jonathan P. Foster. On average, Soliton executives and independent directors trade stock every 126 days with the average trade being worth of $4,763,657. The most recent stock trade was executed by Ventures Llc Remeditex on 30 June 2020, trading 120,481 units of SOLY stock currently worth $999,992.
What does Soliton do?
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
What does Soliton's logo look like?
Complete history of Ventures Remeditex stock trades at Apollo Endosurgery Inc, Bellicum Pharmaceuticals Inc, Menlo Therapeutics, and Soliton
Soliton executives and stock owners
Soliton executives and other stock owners filed with the SEC include:
-
Christopher Capelli,
Vice Chairman of the Board, Chief Scientific Officer -
Walter Klemp,
Executive Chairman of the Board, Co-Founder -
Lori Bisson,
Chief Financial Officer -
Joe Tanner,
Chief Operating Officer -
Jonathan Foster,
Independent Director -
Bradley Hauser,
President, Chief Executive Officer -
Danika Harrison,
Independent Director -
Kaitlyn Brosco,
IR Contact Officer -
Michael Kaminer,
Independent Director -
Niquette Hunt,
Independent Director -
Ventures Llc Remeditex,
10% owner